norelgestromin has been researched along with etonogestrel in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussar, D | 1 |
Evans, SL; Forinash, AB | 1 |
Levine, JP | 1 |
Bifulco, G; Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Nappi, C | 1 |
Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
Kallio, S; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS; Vaskivuo, T | 1 |
Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
2 review(s) available for norelgestromin and etonogestrel
Article | Year |
---|---|
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
2 trial(s) available for norelgestromin and etonogestrel
Article | Year |
---|---|
Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Topics: Absorptiometry, Photon; Amino Acids; Analysis of Variance; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Prospective Studies | 2010 |
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Topics: Administration, Cutaneous; Adult; Anti-Mullerian Hormone; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Norgestrel; Ovarian Follicle; Oximes; Pituitary Gland; Prospective Studies; Young Adult | 2013 |
3 other study(ies) available for norelgestromin and etonogestrel
Article | Year |
---|---|
New drugs 2003, part II.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds | 2003 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |